共 128 条
[1]
Loibl S(2006)Surgical procedures after neoadjuvant chemotherapy in operable breast cancer: results of the GEPARDUO trial Ann Surg Oncol. 13 1434-1442
[2]
von Minckwitz G(2008)Neoadjuvant chemotherapy in invasive breast cancer results in a lower axillary lymph node count J Am Coll Surg. 206 704-708
[3]
Raab G(2001)Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18 J Natl Cancer Inst Monogr. 30 96-102
[4]
Blohmer JU(2001)Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902 J Clin Oncol. 19 4224-4237
[5]
Dan Costa S(2003)The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: preliminary results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27 J Clin Oncol. 21 4165-4174
[6]
Gerber B(2002)Neoadjuvant docetaxel in breast cancer: 3-year survival results from the Aberdeen trial Clin Breast Cancer. 3 S69-S74
[7]
Belanger J(2011)Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials Lancet. 378 1707-1716
[8]
Soucy G(1999)Neoadjuvant chemotherapy for operable breast carcinoma larger than 3 cm: A unicentre randomized trial with a 124-month median follow-up Ann Oncol. 10 47-52
[9]
Sideris L(2001)Surgical conservation planning after neoadjuvant chemotherapy for stage II and operable stage III breast carcinoma Am J Surg. 182 601-608
[10]
Leblanc G(1998)Neoadjuvant therapy in stage II with T ≥ 4CM and stage III breast cancer Eur J Cancer. 34 S33-3835